scholarly journals Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification

2017 ◽  
Vol 66 (2) ◽  
pp. 586-593 ◽  
Author(s):  
Tonghui Lin ◽  
Xue-Lin Wang ◽  
Sara L. Zettervall ◽  
Yujun Cai ◽  
Raul J. Guzman
Bone ◽  
2020 ◽  
Vol 138 ◽  
pp. 115472 ◽  
Author(s):  
Gonzalo Sanchez-Duffhues ◽  
Eleanor Williams ◽  
Marie-Jose Goumans ◽  
Carl-Henrik Heldin ◽  
Peter ten Dijke

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Jiabing Fan ◽  
Joan Pi-Anfruns ◽  
Mian Guo ◽  
Dan C. S. Im ◽  
Zhong-Kai Cui ◽  
...  

2015 ◽  
Vol 368 (1) ◽  
pp. 79-87 ◽  
Author(s):  
Laura D. Hover ◽  
Christian D. Young ◽  
Neil E. Bhola ◽  
Andrew J. Wilson ◽  
Dineo Khabele ◽  
...  

2018 ◽  
Vol 51 (4) ◽  
pp. 1702229 ◽  
Author(s):  
Yanjiang Xing ◽  
Shuang Zhao ◽  
Qingxia Wei ◽  
Shiqiang Gong ◽  
Xin Zhao ◽  
...  

Genetic defects in bone morphogenetic protein type II receptor (BMPRII) signalling and inflammation contribute to the pathogenesis of pulmonary arterial hypertension (PAH). The receptor is activated by bone morphogenetic protein (BMP) ligands, which also enhance BMPR2 transcription. A small-molecule BMP upregulator with selectivity on vascular endothelium would be a desirable therapeutic intervention for PAH.We assayed compounds identified in the screening of BMP2 upregulators for their ability to increase the expression of inhibitor of DNA binding 1 (Id1), using a dual reporter driven specifically in human embryonic stem cell-derived endothelial cells. These assays identified a novel piperidine, BMP upregulator 1 (BUR1), that increased endothelial Id1 expression with a half-maximal effective concentration of 0.098 μmol·L−1. Microarray analyses and immunoblotting showed that BUR1 induced BMP2 and prostaglandin-endoperoxide synthase 2 (PTGS2) expression. BUR1 effectively rescued deficient angiogenesis in autologous BMPR2+/R899X endothelial cells generated by CRISPR/Cas9 and patient cells.BUR1 prevented and reversed PAH in monocrotaline rats, and restored BMPRII downstream signalling and modulated the arachidonic acid pathway in the pulmonary arterial endothelium in the Sugen 5416/hypoxia PAH mouse model.In conclusion, using stem cell technology we have provided a novel small-molecule compound which regulates BMP2 and PTGS2 levels that might be useful for the treatment of PAH.


2017 ◽  
Vol 23 (5-6) ◽  
pp. 195-207 ◽  
Author(s):  
Jiabing Fan ◽  
Mian Guo ◽  
Choong Sung Im ◽  
Joan Pi-Anfruns ◽  
Zhong-Kai Cui ◽  
...  

2009 ◽  
Vol 47 (01) ◽  
Author(s):  
K Breitkopf ◽  
A Müller ◽  
L Ciuclan ◽  
E Wiercinska ◽  
P ten Dijke ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document